Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2020
2020 World Conference on Lung Cancer
Conference Program for the 2020 World Conference on Lung Cancer
Presentation Date(s):- January 28 - 31, 2021
- Total Presentations: 1597
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
FP13 - Immunotherapy (Phase II/III Trials)
- Type: Posters (Featured)
- Track: Immunotherapy (Phase II/III Trials)
- Presentations: 4
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
FP13.01 - 5-Year Survival Update From KEYNOTE-010: Pembrolizumab Versus Docetaxel in Previously Treated, PD-L1–Positive Advanced NSCLC
00:00 - 00:00 | Presenter: Roy S. Herbst
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
FP13.02 - Pembrolizumab + Pemetrexed-Platinum vs Pemetrexed-Platinum for Metastatic NSCLC: 4-Year Follow-up From KEYNOTE-189
00:00 - 00:00 | Presenter: Jhanelle Elaine Gray
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
FP13.03 - IMpower110: Updated OS Analysis of Atezolizumab vs Platinum-Based Chemotherapy as First-Line Treatment in PD-L1–Selected NSCLC
00:00 - 00:00 | Presenter: Roy S. Herbst
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
FP13.04 - KEYNOTE-042 3-Year Survival Update: 1L Pembrolizumab vs Platinum-Based Chemotherapy for PD-L1+ Locally Advanced/Metastatic NSCLC
00:00 - 00:00 | Presenter: Byoung Chul Cho
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
FP14 - Targeted Therapy - Clinically Focused
- Type: Posters (Featured)
- Track: Targeted Therapy - Clinically Focused
- Presentations: 16
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
FP14.02 - A Phase II Study of Osimertinib versus Combination of Osimertinib and Chemotherapy for EGFR and T790M-Mutation Positive NSCLC
00:00 - 00:00 | Presenter: Atsuto Mouri
- Abstract
Loading... -
+
FP14.03 - Osimertinib + Savolitinib in pts with EGFRm MET-Amplified/Overexpressed NSCLC: Phase Ib TATTON Parts B and D Final Analysis
00:00 - 00:00 | Presenter: Ji-Youn Han
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
FP14.04 - Resistance to MET Inhibition in MET Driven NSCLC and Response after Switching from Type I to Type II MET Inhibitors
00:00 - 00:00 | Presenter: Richard Riedel
- Abstract
Loading... -
+
FP14.05 - LIBRETTO-431: Selpercatinib in Treatment-Naïve Patients with RET Fusion-Positive Non-Small Cell Lung Cancer (NSCLC).
00:00 - 00:00 | Presenter: Koichi Goto
- Abstract
Loading... -
+
FP14.06 - Multicenter Analysis of Mechanisms of Resistance to Osimertinib (O) in EGFR Mutated NSCLC: An ATOMIC Registry Study
00:00 - 23:59 | Presenter: Joshua M. Bauml
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
FP14.07 - Combination Osimertinib plus Selpercatinib for EGFR-mutant Non-Small Cell Lung Cancer (NSCLC) with Acquired RET fusions
00:00 - 00:00 | Presenter: Julia K Rotow
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
FP14.08 - Cabozantinib Plus Atezolizumab in NSCLC Patients Previously Treated with a Checkpoint Inhibitor: Results from COSMIC 021
00:00 - 00:00 | Presenter: Joel W Neal
- Abstract
Loading... -
+
FP14.09 - Tepotinib Safety in MET Exon 14 (METex14) Skipping NSCLC: Updated Results from the VISION Trial
00:00 - 00:00 | Presenter: Rémi Veillon
- Abstract
Loading... -
+
FP14.10 - Efficacy and Safety of Selpercatinib (LOXO-292) in East Asian Patients with RET Fusion-Positive NSCLC
00:00 - 00:00 | Presenter: Herbert H Loong
- Abstract
Loading... -
+
FP14.11 - Icotinib versus Chemotherapy as Adjuvant Treatment for Stage II–IIIA EGFR-Mutant NSCLC (EVIDENCE): A Randomized, Open-Label, Phase 3 Study
00:00 - 00:00 | Presenter: Caicun Zhou
- Abstract
Loading... -
+
FP14.12 - Quality of Life and Subgroup Analysis in a Phase 3 Randomized Study of Ensartinib vs Crizotinib in ALK–Positive NSCLC Patients: eXalt3.
00:00 - 00:00 | Author(s): giovanni Selvaggi
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
FP14.13 - Molecular Characterisation and Clinical Outcomes in RET Rearranged Non-Small Cell Lung Cancer (NSCLC)
00:00 - 00:00 | Presenter: Aaron C Tan
- Abstract
Loading... -
+
FP14.14 - Post Hoc Analyses from an Open Label, Multi-Centre, ASTRIS Trial of Efficacy of Osimertinib for CNS Metastases with T790M-Positive Advanced NSCLC
00:00 - 00:00 | Presenter: Beung-Chul Ahn
- Abstract
Loading... -
+
FP14.15 - Neratinib-Based Combination Therapy in HER2-Mutant Lung Adenocarcinomas: Findings from two International Phase 2 Studies.
00:00 - 00:00 | Presenter: Bob T. Li
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
FP14.16 - Phase 2 Trial of the Alternating Therapy with Osimertinib and Afatinib for Treatment-Naive Patients with EGFR-Mutated Advanced Non–Small Cell Lung Cancer (WJOG10818L/Alt Trial)
00:00 - 00:00 | Presenter: Hidetoshi Hayashi
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
FP14.17 - Efficacy and Safety of Pralsetinib in Chinese Patients with Advanced RET Fusion+ Non-Small Cell Lung Cancer after Platinum-Based Chemotherapy
00:00 - 00:00 | Presenter: Qing Zhou
- Abstract
Loading...
-
+
P01 - Antibody Drug Conjugates, Novel Therapeutics and Cytotoxics
- Type: Posters
- Track: Antibody Drug Conjugates, Novel Therapeutics and Cytotoxics
- Presentations: 24
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P01.01 - HERTHENA-Lung01: A Randomized Phase 2 Study of Patritumab Deruxtecan (HER3-DXd; U3-1402) in Previously Treated Metastatic EGFR-mutated NSCLC
00:00 - 00:00 | Presenter: Pasi A. Janne
- Abstract
Loading... -
+
P01.02 - Trastuzumab Deruxtecan Plus Pembrolizumab in Advanced/Metastatic Breast or Non-Small Cell Lung Cancer: A Phase 1b Study
00:00 - 00:00 | Presenter: Hossein Borghaei
- Abstract
Loading... -
+
P01.03 - Phase 1 Study of Patritumab Deruxtecan (HER3-DXd; U3-1402) in Combination with Osimertinib in Patients with Locally Advanced or Metastatic EGFR-mutated NSCLC
00:00 - 00:00 | Presenter: Pasi Antero Jänne
- Abstract
Loading... -
+
P01.04 - Dynamics of Molecular Markers in EGFR-Mutated NSCLC Patients Treated with Patritumab Deruxtecan (HER3-DXd; U3-1402)
00:00 - 00:00 | Presenter: Pasi Antero Jänne
- Abstract
Loading... -
+
P01.05 - Pilot Study of Inhaled Azacitidine in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
00:00 - 00:00 | Presenter: Haiying Cheng
- Abstract
Loading... -
+
P01.06 - CX-2029, a Probody Drug Conjugate Targeting CD71 in Patients With Selected Tumor Types: PROCLAIM-CX-2029 Dose Expansion Phase
00:00 - 00:00 | Presenter: Melissa L Johnson
- Abstract
Loading... -
+
P01.07 - Real World Outcomes of Advanced Non-Small Cell Lung Cancer (NSCLC) With Attention to Carboplatin Area Under the Curve (AUC) = 5 Versus 6
00:00 - 00:00 | Presenter: Lindsey Fitzgerald
- Abstract
Loading... -
+
P01.08 - Evaluation of Long-Term Pemetrexed Responders in a United States Cohort
00:00 - 00:00 | Presenter: Sylvia Vania Alarcon
- Abstract
Loading... -
+
P01.09 - Improved Outcomes With Ramucirumab & Docetaxel in Metastatic Non-Small Cell Lung Cancer After Failure of Immunotherapy
00:00 - 00:00 | Author(s): Richa Dawar
- Abstract
Loading... -
+
P01.10 - Patients Experienced Pseudoprogression to Anti-PD-1/PD-L1 Inhibitor Have Better Response Than Those Without in Lung Cancer
00:00 - 00:00 | Presenter: Wencheng Zhao
- Abstract
Loading... -
+
P01.11 - Clinical Outcomes After Discontinuation of Immunotherapy in Patients With Non-Progressing Metastatic Lung Cancer
00:00 - 00:00 | Presenter: Matias Alejandro Cerini
- Abstract
Loading... -
+
P01.12 - Brain Necrosis in Patients With Metastatic Lung and Breast Cancer Successfully Treated With Bevacizumab
00:00 - 00:00 | Presenter: Luis E. Raez
- Abstract
Loading... -
+
P01.13 - Anti-PD1 Inhibitors Combined With Anti-Angiogenesis Showed Superior Efficacy in Control of Malignant Pleural Effusion for NSCLC
00:00 - 00:00 | Presenter: Wencheng Zhao
- Abstract
Loading... -
+
P01.14 - Safety and Feasibility of Standard Dosing Carboplatin AUC 5 Every 3rd Weeks With Daily Navelbine® 20/30mg During 4 Cycles, Treating Advanced NSCLC
00:00 - 00:00 | Presenter: Maria Kandi
- Abstract
Loading... -
+
P01.15 - Immune-Related Adverse Effects of Immunotherapy in Patients With Advanced Non-Small Cell Lung Carcinoma
00:00 - 00:00 | Presenter: Cláudia Freitas
- Abstract
Loading... -
+
P01.16 - Tamoxifen Might Enhance the Effect of EGFR-TKIs on EGFR-Mutant NSCLC Cells
00:00 - 00:00 | Presenter: Yun-Ting He
- Abstract
Loading... -
+
P01.17 - An Exploratory Study of Associating Factors for Disease Progression After Response to Immune Checkpoint Inhibitor Monotherapy
00:00 - 00:00 | Presenter: Osamu Kanai
- Abstract
Loading... -
+
P01.18 - Adjuvant Chemotherapy With Modified Nab-Paclitaxel and Carboplatin for Completely Resected NSCLC: Survival Analysis of FAST-Nab.
00:00 - 00:00 | Presenter: HISASAHI Saji
- Abstract
Loading... -
+
P01.19 - Real-World Treatment Patterns in Treatment-Naïve Advanced NSCLC Patients in Asia: A Systematic Literature Review
00:00 - 00:00 | Author(s): Mariana Oviedo Ovando
- Abstract
Loading... -
+
P01.20 - Short-Term Effificacy of Intrapleural Hyperthermic Perfusion for Malignant Pleural Effusion in Lung Carcinoma
00:00 - 00:00 | Presenter: Minhua Ye
- Abstract
Loading... -
+
P01.21 - ANSELMA: Antiangiogenic Second Line Lung Cancer Meta-Analysis on Individual Patient Data in Non-Small Cell Lung Cancer, Again Relevant in ICI Era
00:00 - 00:00 | Presenter: Jordi Remon
- Abstract
Loading... -
+
P01.22 - Outcomes in NSCLC Patients with Early Termination of Immune Checkpoint Inhibitors Due to Toxicities
00:00 - 00:00 | Presenter: Amy Georgina Davies
- Abstract
Loading... -
+
P01.23 - Veliparib (V) in Combination with Carboplatin/Paclitaxel (C/P)-Based Chemoradiotherapy (CRT) in Patients With Stage III NSCLC
00:00 - 00:00 | Presenter: David Kozono
- Abstract
Loading... -
+
P01.24 - Ramucirumab + Docetaxel (DOC) vs PBO + DOC for Stage IV NSCLC after Disease Progression (REVEL): Indian Sub-Group Analysis
00:00 - 00:00 | Presenter: Kumar Prabhash
- Abstract
Loading...
-
+
P02 - Diagnostics and Interventional Pulmonology
- Type: Posters
- Track: Diagnostics and Interventional Pulmonology
- Presentations: 25
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P02.01 - Evaluation of PFS for Pulmonary Adenocarcinoma Patient Treated With EGFR Tyrosine Kinase Inhibitors Using Deep Learning Based on CT Image
00:00 - 00:00 | Presenter: Junfeng Xiong
- Abstract
Loading... -
+
P02.02 - Pulmonary Rebiopsy is ‘Here to Stay’ in Non-Small Cell Lung Carcinoma (NSCLC) Patients with Progression on Tyrosine Kinase Inhibitors (TKIs)
00:00 - 00:00 | Author(s): Ullas Batra
- Abstract
Loading... -
+
P02.03 - Comparison of the Efficiency of 22G Versus 25G Needle in EBUS-TBNA for Diagnosis of Lung Cancer; A Prospective Randomized, Crossover Study.
00:00 - 00:00 | Presenter: Tetsuya Sakai
- Abstract
Loading... -
+
P02.04 - Pectoral Muscle Area Correlates with LENT Score in Non-Small Cell Lung Cancer Associated Pleural Effusion Survival Prediction
00:00 - 00:00 | Presenter: Austin Michael Meggyesy
- Abstract
Loading... -
+
P02.05 - A Nomogram to Predict Survival in Non-Small Cell Lung Cancer Patients Receiving Atezolizumab: An Analysis of OAK and POPLAR Cohorts
00:00 - 00:00 | Author(s): Xiaoling Shang
- Abstract
Loading... -
+
P02.06 - A Novel Loop-Mediated Isothermal Amplification Method for Robust Detection of EGFR Mutations
00:00 - 00:00 | Presenter: YUICHI Saito
- Abstract
Loading... -
+
P02.07 - Impact of Diagnostic Test Sequencing on Effectiveness, Efficiency and Survival in Metastatic Non-Small Cell Lung Cancer.
00:00 - 00:00 | Author(s): Lauren Ng
- Abstract
Loading... -
+
P02.08 - A UK Survey of Current Methods for Conducting Cancer Multidisciplinary Team Meetings and Opportunities for Digital Solutions.
00:00 - 00:00 | Presenter: Clarissa Gardner
- Abstract
Loading... -
+
P02.09 - Comprehensive Investigation of Resected Benign Lesions Suspected for Lung Cancer: Implications for Avoiding Unnecessary Pulmonary Resection
00:00 - 00:00 | Presenter: Zelin Ma
- Abstract
Loading... -
+
P02.10 - Patterns of Care for Elderly Patients over Age 80 with Stage IIIA-N2, IIIB, and IIIC NSCLC
00:00 - 00:00 | Presenter: Yajie Yin
- Abstract
Loading... -
+
P02.11 - Treatment Strategy for Postoperative Chylothorax after Lung Cancer Surgery
00:00 - 00:00 | Presenter: Chihaya Maeda
- Abstract
Loading... -
+
P02.12 - Is there a Need for Staging EBUS in Lung Cancer?
00:00 - 00:00 | Presenter: Avinash Aujayeb
- Abstract
Loading... -
+
P02.13 - Pneumothorax and CT Guided Biopsy for the Investigation of Lung Cancer
00:00 - 00:00 | Author(s): Mohammad Moad
- Abstract
Loading... -
+
P02.14 - Radiotherapy-Associated CT Imaging as a Potential Screening Tool for COVID-19
00:00 - 00:00 | Presenter: Abraham J Wu
- Abstract
Loading... -
+
P02.15 - Intraparenchymal Blood Patch after CT Guided Biopsy of Lung and Mediastinal Lesions Reduces the Risk of Pneumothorax
00:00 - 00:00 | Presenter: Binoy Kumar Choudhury
- Abstract
Loading... -
+
P02.16 - Rigid Medical Thoracoscopy in a Large UK District General Hospital
00:00 - 00:00 | Presenter: Avinash Aujayeb
- Abstract
Loading... -
+
P02.17 - Feasibility and Safety of ENB Guided Microwave Ablation for Lung Cancer: A Preliminary Report
00:00 - 00:00 | Presenter: Feichao Bao
- Abstract
Loading... -
+
P02.18 - Indwelling Pleural Catheter Placement in a Large UK District General Hospital
00:00 - 00:00 | Presenter: Avinash Aujayeb
- Abstract
Loading... -
+
P02.19 - Prognostic Nomogram for Advanced Non-Small Cell Lung Cancer Patients Treated With Anti-PD-1 Inhibitors
00:00 - 00:00 | Presenter: Rong Chai
- Abstract
Loading... -
+
P02.20 - Does Response at 1st Scan Imaging After Any Line Correlate With PFS?
00:00 - 00:00 | Presenter: FADI Nasr
- Abstract
Loading... -
+
P02.21 - The Impact of Inflammatory Serum Biomarkers in Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors
00:00 - 00:00 | Presenter: Élia Rodrigues Cipriano
- Abstract
Loading... -
+
P02.22 - Identification of FGFR Mutations in Chinese Lung Cancer Patients by Next-Generation Sequencing
00:00 - 00:00 | Presenter: HONGXIA Ma
- Abstract
Loading... -
+
P02.23 - Robotic Thoracic Surgery - A Comparison of Age-Groups Outcomes.
00:00 - 00:00 | Presenter: Rui Haddad
- Abstract
Loading... -
+
P02.24 - Liquid Biopsy Mutation Profiling in Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Vaida Gedvilaitė
- Abstract
Loading... -
+
P02.25 - Coexistence of Invasive Adenocarcinoma, Minimally Invasive Adenocarcinoma and Atypical Adenomatous Hyperplasia: A Case Report
00:00 - 00:00 | Presenter: Kewei Ma
- Abstract
Loading...
-
+
P03 - Early Stage/Localized Disease - Clinical Trials in Progress
- Type: Posters
- Track: Early Stage/Localized Disease
- Presentations: 6
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P03.01 - A Randomized Phase II Trial of Adjuvant Pembrolizumab vs Observation after Curative Resection for Stage I NSCLC with Primary Tumors Between 1-4 cm
00:00 - 00:00 | Presenter: Gregory A Durm
- Abstract
Loading... -
+
P03.02 - Neoadjuvant Osimertinib with/without Chemotherapy vs Chemotherapy for EGFR Mutated Resectable NSCLC: NeoADAURA
00:00 - 00:00 | Presenter: Masahiro Tsuboi
- Abstract
Loading... -
+
P03.03 - MERMAID-1: A Phase III Study of Adjuvant Durvalumab plus Chemotherapy in Resected NSCLC Patients with MRD+ Post-Surgery
00:00 - 00:00 | Presenter: Solange Peters
- Abstract
Loading... -
+
P03.04 - Phase II Study of TKIs as Neo(adjuvant) Therapy in Stage II–III Resectable NSCLC with ALK, ROS1, NTRK or BRAFV600 Alterations
00:00 - 00:00 | Presenter: Jay M. Lee
- Abstract
Loading... -
+
P03.05 - CANOPY-N: Neoadjuvant Canakinumab and Pembrolizumab in Patients With Surgically Resectable Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Jay M. Lee
- Abstract
Loading... -
+
P03.06 - Nausea in Patients Had Thoracomy: A Pilot Study
00:00 - 00:00 | Author(s): Fan Zhang
- Abstract
Loading...
-
+
P04 - Early Stage/Localized Disease - Perioperative Therapy (Neoadjuvant Therapy, Surgery, Adjuvant Therapy)
- Type: Posters
- Track: Early Stage/Localized Disease
- Presentations: 11
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P04.01 - Adjuvant Chemotherapy is not Associated with Worse Disease-Free Survival in the Elderly Population.
00:00 - 00:00 | Presenter: Luciana Beatriz Mendes Gomes
- Abstract
Loading... -
+
P04.02 - Three Definitions of Normal Lung Volumes for Predicting Radiation Pneumonitis in Advanced NSCLC Treated With Radical Chemoradiation Therapy
00:00 - 00:00 | Presenter: zhiyong Chen
- Abstract
Loading... -
+
P04.03 - Patient Characteristics and Clinical Outcomes of Stage III NSCLC in a Real-World Setting: KINDLE Korean Subset Data.
00:00 - 00:00 | Presenter: Byoung Chul Cho
- Abstract
Loading... -
+
P04.04 - Thrombus Formation at Stump of Pulmonary Vein after Pulmonary Lobectomy: A Prospective Multi-institutional Study
00:00 - 00:00 | Presenter: Takayoshi Yamamoto
- Abstract
Loading... -
+
P04.05 - Efficacy of Uniportal Video-Assisted Thoracic Surgery (U-VATS) Simple Segmentectomy for Early Lung Cancer
00:00 - 00:00 | Presenter: Kyoji Hirai
- Abstract
Loading... -
+
P04.06 - Early Surgical and Oncological Outcomes After Single Port Video Assisted Thoracoscopic Surgery Lung Resection; KHCC Experience
00:00 - 00:00 | Presenter: riad Amin Abdeljalil
- Abstract
Loading... -
+
P04.07 - Long-term Postoperative Prognosis of Adenocarcinoma in Situ and Minimally Invasive Adenocarcinoma of Lung
00:00 - 00:00 | Presenter: Masaya Yotsukura
- Abstract
Loading... -
+
P04.08 - Dynamics of Coagulation Factor XIII Activity After Thoracoscopic Lobectomy for Early-Stage Lung Cancer Patients
00:00 - 00:00 | Presenter: Yoshikane Yamauchi
- Abstract
Loading... -
+
P04.09 - Real-Time CT Guided Video-Assisted Thoracoscopic Partial Resection of Peripheral Small-Sized Lung Tumors in Hybrid OR –A Phase 2 Trial–
00:00 - 00:00 | Presenter: Taisuke Kaiho
- Abstract
Loading... -
+
P04.10 - Relapsed or Metastatic Organotropism in Early Stage Lung Cancer after Radical Surgery
00:00 - 00:00 | Presenter: Fei Xu
- Abstract
Loading... -
+
P04.12 - A Novel Lung Autotransplantation Technique for Treating Central Lung Cancer and Bronchial Malignancy
00:00 - 00:00 | Presenter: JIAXI He
- Abstract
Loading...
-
+
P05 - Early Stage/Localized Disease - Radiotherapy
- Type: Posters
- Track: Early Stage/Localized Disease
- Presentations: 14
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P05.01 - Multicenter Retrospective Study of Stereotactic Body Radiotherapy in Non-Small Cell Lung Cancer in South Korea (KROG 17-09)
00:00 - 00:00 | Presenter: Seung Gyu Park
- Abstract
Loading... -
+
P05.02 - International Delphi Consensus on Radical Thoracic Re-Irradiation for Non-Small Cell Lung Cancer (NSCLC)
00:00 - 00:00 | Presenter: Robert Rulach
- Abstract
Loading... -
+
P05.03 - Circulating Lymphocyte Counts after Lung Stereotactic Body Radiation Therapy May Predict after Optimal Short-term Efficacy
00:00 - 00:00 | Presenter: Meng Chen
- Abstract
Loading... -
+
P05.04 - Association of Lymphopenia and Disease Progression in Unresectable NSCLC Treated with Definitive Chemoradiation and Immunotherapy
00:00 - 00:00 | Presenter: Cole Friedes
- Abstract
Loading... -
+
P05.05 - Real-World Data on Patients With Stage I Non-Small Cell Lung Cancer Treated With Stereotactic Body Radiotherapy (SBRT)
00:00 - 00:00 | Presenter: Lisa Van Der Woude
- Abstract
Loading... -
+
P05.06 - Stereotactic Ablative Radiotherapy for Early Stage Non-Small Lung Cancer and Pulmonary Oligometastases in a New Zealand Population
00:00 - 00:00 | Presenter: Nur Azri Bin Haji Mohd Yasin
- Abstract
Loading... -
+
P05.07 - Single-Fraction Carbon ion Radiotherapy for Patients with Early-Stage Lung Cancer with or without Interstitial Pneumonitis
00:00 - 00:00 | Presenter: Takashi Ono
- Abstract
Loading... -
+
P05.08 - A Propensity Score-Weighted Analysis for SBRT, Lobectomy and Sublobar Resection in Elderly Patients with cStage I NSCLC
00:00 - 00:00 | Presenter: Noriko Kishi
- Abstract
Loading... -
+
P05.09 - Thoracic Re-Irradiation Dose Constraints for Late Lung Fibrosis: Preliminary Modelling Results
00:00 - 00:00 | Presenter: Robert Rulach
- Abstract
Loading... -
+
P05.10 - Risk Factors Associated with Pulmonary Toxicities from Multiple Courses of Lung Stereotactic Body Radiation Therapy (SBRT)
00:00 - 00:00 | Presenter: Xingzhe Li
- Abstract
Loading... -
+
P05.11 - Preoperative Low Muscle Quality Predicts Poor Outcomes After Surgery for Early-Stage Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Atsushi Kamigaichi
- Abstract
Loading... -
+
P05.12 - Hospitalisation Rate in Radical Re-Irradiation of NSCLC are no Different Between Local Recurrences or Second Primaries
00:00 - 00:00 | Presenter: Robert Rulach
- Abstract
Loading... -
+
P05.13 - Central vs Peripheral Thoracic Malignancies Treated with SBRT: Early Outcomes of a Prospective Quality of Life Study
00:00 - 00:00 | Presenter: Michael Carrasquilla
- Abstract
Loading... -
+
P05.14 - Dosimetric Impact of Using the Acuros XB for Planning of SBRT of Centrally Located NSCLC
00:00 - 00:00 | Presenter: Hing Ming Hung
- Abstract
Loading...
-
+
P06 - Early Stage/Localized Disease - Multiple Primary Lung Cancer
- Type: Posters
- Track: Early Stage/Localized Disease
- Presentations: 4
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P06.01 - Therapeutic Strategies for Metachronous Multiple Primary Lung Cancer
00:00 - 00:00 | Presenter: Jitsuo Usuda
- Abstract
Loading... -
+
P06.02 - Prognostic Factors and Strategies for Metachronous Second Primary Lung Cancer
00:00 - 00:00 | Presenter: Dai Shimizu
- Abstract
Loading... -
+
P06.03 - Regression of the Ground Glass Component in Patients with Multifocal Primary Lung Cancers Receiving Pembrolizumab
00:00 - 00:00 | Presenter: Jessica Li
- Abstract
Loading... -
+
P06.04 - Single-Stage Bilateral Pulmonary Resections by Uniportal Video-Assisted Thoracic Surgery for Multiple Small Nodules
00:00 - 00:00 | Author(s): ShengCheng Lin
- Abstract
Loading...
-
+
P07 - Early Stage/Localized Disease - Imaging and Biomarkers
- Type: Posters
- Track: Early Stage/Localized Disease
- Presentations: 8
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P07.01 - Less Accuracy of CT and PET in the Evaluation of N1 Node may Result in Overlooking Skip Metastasis of Single Station cN2 Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Satoshi Shiono
- Abstract
Loading... -
+
P07.02 - Detection of Molecular Residual Disease (MRD) using ctDNA in NSCLC: A Systematic Review and Meta-Analysis
00:00 - 00:00 | Presenter: Antonio Galvano
- Abstract
Loading... -
+
P07.03 - The Impact of PD-L1 Expression on the Prognosis of Early-Stage Resected NSCLC: A Meta-Analysis of Literatures.
00:00 - 00:00 | Presenter: Shuai Zhu
- Abstract
Loading... -
+
P07.04 - Using ctDNA to Detect Minimal Residual Disease after Surgery in Resectable Lung Cancer
00:00 - 00:00 | Presenter: Jun Huang
- Abstract
Loading... -
+
P07.05 - Characterization of Clinicopathologic Features and Molecular Recurrence Risk Profiles in Patients with Early-Stage NSCLC
00:00 - 00:00 | Presenter: Sara Riordan
- Abstract
Loading... -
+
P07.06 - Automated Flow Cytometry Test Distinguishes Cancer from Non-Cancer in Sputum with High Sensitivity and Specificity
00:00 - 00:00 | Presenter: Vivienne Ilona Rebel
- Abstract
Loading... -
+
P07.07 - Computed Tomography of Lymph Nodes to Predict Occult pN2 Disease in Non-Small-Cell Lung Cancer
00:00 - 00:00 | Presenter: Hiroto Onozawa
- Abstract
Loading... -
+
P07.08 - IDO Immune Suppression and Post Surgical Toxicity in Patients with Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Dazhi Pang
- Abstract
Loading...
-
+
P08 - Early Stage/Localized Disease - Epidemiology
- Type: Posters
- Track: Early Stage/Localized Disease
- Presentations: 9
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P08.01 - Prognostic Impact of Second Predominant Pattern in Lung Adenocarcinoma: Analysis From a Large Multicentric European Database
00:00 - 00:00 | Presenter: Pietro Bertoglio
- Abstract
Loading... -
+
P08.03 - Clinicopathological Factors Associated With Recurrence Patterns of Resected Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Tomonari Kinoshita
- Abstract
Loading... -
+
P08.04 - Progress in Early Stage Lung Cancer Among Economically Disadvantaged Patients
00:00 - 00:00 | Author(s): Mohamed Rahouma
- Abstract
Loading... -
+
P08.05 - Risk Factors Associated with Recurrence Following Curative Therapy for Stage I NSCLC
00:00 - 00:00 | Presenter: Emily Brooke Butts
- Abstract
Loading... -
+
P08.06 - Factors Associated with the Diagnosis of Lymphatic Vascular Invasion and its Impact on Prognosis.
00:00 - 00:00 | Author(s): John Michael Varlotto
- Abstract
Loading... -
+
P08.07 - Clinical Characteristics and Treatment Patterns of NSCLC Stage III Patients from Real World
00:00 - 00:00 | Author(s): Louis Kathmann
- Abstract
Loading... -
+
P08.08 - Surgical Resection of Non-Small Cell Lung Cancer: Uncertain Resection Margins and Patterns of Recurrence
00:00 - 00:00 | Presenter: Hannah Emily Scholes
- Abstract
Loading... -
+
P08.09 - Optimal Follow Up Care for Patients with P-stage I Non-Small Cell Lung Cancer After Surgical Treatment
00:00 - 00:00 | Presenter: Hirotsugu Notsuda
- Abstract
Loading... -
+
P08.10 - Clinical Characteristics and Outcomes of Simultaneous Multiple Primary Lung Cancer with Same Pathological Types
00:00 - 00:00 | Presenter: Ying Liu
- Abstract
Loading...
first
prev
